• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Yes相关蛋白1通过激活ERK/MAPK信号通路促进甲状腺乳头状癌细胞增殖。

Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.

作者信息

Liao Tian, Wen Duo, Ma Ben, Hu Jia-Qian, Qu Ning, Shi Rong-Liang, Liu Liang, Guan Qing, Li Duan-Shu, Ji Qing-Hai

机构信息

Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

Department of Breast Surgery, Breast Cancer Institute, Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Oncotarget. 2017 Feb 14;8(7):11719-11728. doi: 10.18632/oncotarget.14319.

DOI:10.18632/oncotarget.14319
PMID:28036290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5355298/
Abstract

Yes-associated protein 1 (YAP1) stimulates cell proliferation, epithelial-to-mesenchymal transition, invasion and metastasis in several cancers. Here, we investigated the involvement of YAP1 in papillary thyroid carcinoma (PTC) by assessing YAP1 mRNA and protein levels in PTC tissues and matched normal thyroid epithelial tissues from 50 patients. YAP1 mRNA and protein levels were higher in PTC tumor tissues than in control tissues, and correlated positively with the levels of proliferation-related genes (KI67 and c-MYC). We also used lentiviral vectors to overexpress or silence YAP1 expression in the K1 PTC cell line so that we could investigate the effects of YAP1 on cancer cell proliferation. YAP1 overexpression enhanced PTC cell proliferation by activating ERK1/2 and AKT, and these effects were impaired by treating the cells with the MEK inhibitor U0126 or the AKT inhibitor GSK690693. Finally, YAP1 overexpression dramatically induced growth of tumors from PTC cells in a xenograft mouse model. These results suggest that YAP1 enhances cell proliferation in PTC, and thus may be a promising target in the treatment of PTC.

摘要

Yes相关蛋白1(YAP1)在多种癌症中可刺激细胞增殖、上皮-间质转化、侵袭和转移。在此,我们通过评估50例患者的甲状腺乳头状癌(PTC)组织及配对的正常甲状腺上皮组织中YAP1的mRNA和蛋白水平,来研究YAP1在PTC中的作用。PTC肿瘤组织中YAP1的mRNA和蛋白水平高于对照组织,且与增殖相关基因(KI67和c-MYC)的水平呈正相关。我们还使用慢病毒载体在K1 PTC细胞系中过表达或沉默YAP1的表达,以便研究YAP1对癌细胞增殖的影响。YAP1的过表达通过激活ERK1/2和AKT增强了PTC细胞的增殖,而用MEK抑制剂U0126或AKT抑制剂GSK690693处理细胞会削弱这些作用。最后,YAP1的过表达在异种移植小鼠模型中显著诱导了PTC细胞肿瘤的生长。这些结果表明,YAP1增强了PTC中的细胞增殖,因此可能是PTC治疗中一个有前景的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/1fc163ba8902/oncotarget-08-11719-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/70c812f3339b/oncotarget-08-11719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/85c089faace2/oncotarget-08-11719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/cf9ee8e4a95e/oncotarget-08-11719-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/0b2230680062/oncotarget-08-11719-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/1fc163ba8902/oncotarget-08-11719-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/70c812f3339b/oncotarget-08-11719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/85c089faace2/oncotarget-08-11719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/cf9ee8e4a95e/oncotarget-08-11719-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/0b2230680062/oncotarget-08-11719-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ec/5355298/1fc163ba8902/oncotarget-08-11719-g005.jpg

相似文献

1
Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.Yes相关蛋白1通过激活ERK/MAPK信号通路促进甲状腺乳头状癌细胞增殖。
Oncotarget. 2017 Feb 14;8(7):11719-11728. doi: 10.18632/oncotarget.14319.
2
CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.CRLF1 通过激活 MAPK/ERK 和 PI3K/AKT 通路促进甲状腺乳头状癌的恶性表型。
Cell Death Dis. 2018 Mar 7;9(3):371. doi: 10.1038/s41419-018-0352-0.
3
LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.长链非编码 RNA SNHG15 通过海绵吸附 miR-200a-3p 调控 YAP1-Hippo 信号通路在甲状腺乳头状癌中的作用。
Cell Death Dis. 2018 Sep 20;9(10):947. doi: 10.1038/s41419-018-0975-1.
4
BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.BRAF激活的长链非编码RNA在甲状腺乳头状癌中发挥肿瘤抑制作用。
Oncotarget. 2017 Jan 3;8(1):238-247. doi: 10.18632/oncotarget.10825.
5
The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.DLG1-AS1/miR-497/YAP1 轴调控甲状腺乳头状癌细胞的进展。
Aging (Albany NY). 2020 Nov 16;12(22):23326-23336. doi: 10.18632/aging.104121.
6
Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.长链非编码 RNA 癌症易感性候选基因 2 通过失活 AKT/ERK1/2 信号通路抑制甲状腺乳头状癌生长。
J Cell Biochem. 2019 Jun;120(6):10380-10390. doi: 10.1002/jcb.28322. Epub 2019 Jan 4.
7
MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.MiR-20b通过调节MAPK/ERK信号通路在甲状腺乳头状癌中发挥肿瘤抑制功能。
Thyroid. 2016 Dec;26(12):1733-1743. doi: 10.1089/thy.2015.0578. Epub 2016 Nov 2.
8
Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.敲低 ANXA10 通过下调 TSG101 抑制甲状腺乳头状癌细胞的增殖并促进其凋亡,从而使 MAPK/ERK 信号通路失活。
J Bioenerg Biomembr. 2021 Aug;53(4):429-440. doi: 10.1007/s10863-021-09902-7. Epub 2021 May 25.
9
Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.下调 CSN6 通过降低 Wnt/β-catenin 信号通路抑制甲状腺乳头状癌细胞的进展并增加癌细胞对 FH535 治疗的敏感性。
Cancer Med. 2018 Feb;7(2):285-296. doi: 10.1002/cam4.1272. Epub 2018 Jan 17.
10
MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.MicroRNA-31 通过直接靶向 SOX11 并调节上皮间质转化、ERK 和 Akt 信号通路抑制甲状腺乳头状癌细胞的生物学进展。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5863-5873. doi: 10.26355/eurrev_201907_18329.

引用本文的文献

1
Transcriptomics insights into glutamine on repairing of histamine-induced Yak rumen epithelial cells barrier damage in vitro.转录组学揭示谷氨酰胺对体外组胺诱导的牦牛瘤胃上皮细胞屏障损伤修复的影响
BMC Genomics. 2025 Feb 25;26(1):195. doi: 10.1186/s12864-025-11383-6.
2
Preclinical studies of natural flavonoids in inflammatory bowel disease based on macrophages: a systematic review with meta-analysis and network pharmacology.基于巨噬细胞的天然黄酮类化合物在炎症性肠病中的临床前研究:一项荟萃分析和网络药理学的系统评价
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2293-2318. doi: 10.1007/s00210-024-03501-0. Epub 2024 Oct 18.
3

本文引用的文献

1
Changing Trends in the Incidence of Thyroid Cancer in the United States.美国甲状腺癌发病率的变化趋势
JAMA Otolaryngol Head Neck Surg. 2016 Jul 1;142(7):709-11. doi: 10.1001/jamaoto.2016.0230.
2
EDAG-1 promotes proliferation and invasion of human thyroid cancer cells by activating MAPK/Erk and AKT signal pathways.EDAG-1通过激活MAPK/Erk和AKT信号通路促进人甲状腺癌细胞的增殖和侵袭。
Cancer Biol Ther. 2016 Apr 2;17(4):414-21. doi: 10.1080/15384047.2016.1156259. Epub 2016 Mar 2.
3
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
YAP1 and P53 Expression in Papillary Thyroid Carcinoma.
YAP1和P53在甲状腺乳头状癌中的表达
Iran J Pathol. 2023;18(1):49-56. doi: 10.30699/IJP.2023.553716.2897. Epub 2023 Mar 23.
4
HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression.缺氧诱导因子 1α/Yes 相关蛋白信号通路重编程葡萄糖/碘代谢程序促进甲状腺乳头状癌进展。
Int J Biol Sci. 2023 Jan 1;19(1):225-241. doi: 10.7150/ijbs.75459. eCollection 2023.
5
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma.环状和长非编码 RNA 在皮肤黑色素瘤中的多功能作用。
Mol Oncol. 2022 Feb;16(3):565-593. doi: 10.1002/1878-0261.13034. Epub 2021 Jun 18.
6
The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.DLG1-AS1/miR-497/YAP1 轴调控甲状腺乳头状癌细胞的进展。
Aging (Albany NY). 2020 Nov 16;12(22):23326-23336. doi: 10.18632/aging.104121.
7
Immortalization up-regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer.永生化蛋白促进甲状腺乳头状癌的发生和抑制细胞凋亡。
J Cell Mol Med. 2020 Dec;24(23):14059-14072. doi: 10.1111/jcmm.16018. Epub 2020 Oct 23.
8
Expression of miR-195 and MEK1 in patients with bladder cancer and their relationship to prognosis.miR-195和MEK1在膀胱癌患者中的表达及其与预后的关系。
Int J Clin Exp Pathol. 2019 Mar 1;12(3):843-850. eCollection 2019.
9
miR-16 regulates proliferation and invasion of lung cancer cells via the ERK/MAPK signaling pathway by targeted inhibition of MAPK kinase 1 (MEK1).微小RNA-16通过靶向抑制丝裂原活化蛋白激酶激酶1(MEK1),经由细胞外信号调节激酶/丝裂原活化蛋白激酶(ERK/MAPK)信号通路调控肺癌细胞的增殖与侵袭。
J Int Med Res. 2019 Oct;47(10):5194-5204. doi: 10.1177/0300060519856505. Epub 2019 Aug 4.
10
Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis.CKAP2L表达上调促进肺腺癌侵袭并与不良预后相关。
Onco Targets Ther. 2019 Feb 12;12:1171-1180. doi: 10.2147/OTT.S182242. eCollection 2019.
低分化和间变性甲状腺癌的基因组和转录组特征
J Clin Invest. 2016 Mar 1;126(3):1052-66. doi: 10.1172/JCI85271. Epub 2016 Feb 15.
4
The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.YAP1癌基因通过调控H19长链非编码RNA促进膀胱癌细胞的增殖和迁移。
Urol Oncol. 2015 Oct;33(10):427.e1-10. doi: 10.1016/j.urolonc.2015.06.003. Epub 2015 Jul 9.
5
Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.葡萄糖通过AMPK/mTOR/S6和MAPK信号通路促进子宫内膜癌细胞的增殖、葡萄糖摄取和侵袭。
Gynecol Oncol. 2015 Sep;138(3):668-75. doi: 10.1016/j.ygyno.2015.06.036. Epub 2015 Jun 30.
6
Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.YAP内源性激活突变揭示的Hippo信号活性的稳态控制
Genes Dev. 2015 Jun 15;29(12):1285-97. doi: 10.1101/gad.264234.115.
7
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression.YAP抑制可恢复晚期肝癌中的肝细胞分化,导致肿瘤消退。
Cell Rep. 2015 Mar 17;10(10):1692-1707. doi: 10.1016/j.celrep.2015.02.027. Epub 2015 Mar 12.
8
Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients.致癌基因YAP1与结直肠癌患者预后不良和西妥昔单抗耐药显著相关。
Clin Cancer Res. 2015 Jan 15;21(2):357-64. doi: 10.1158/1078-0432.CCR-14-1374. Epub 2014 Nov 11.
9
Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway.Yes 相关蛋白 1(YAP1)通过激活 AXL/MAPK 通路促进人胆囊肿瘤生长。
Cancer Lett. 2014 Dec 28;355(2):201-9. doi: 10.1016/j.canlet.2014.08.036. Epub 2014 Sep 10.
10
Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells.肌原纤维生成调节因子-1的磷酸化激活丝裂原活化蛋白激酶信号通路并诱导人乳腺癌MCF7细胞增殖和迁移。
FEBS Lett. 2014 Aug 25;588(17):2903-10. doi: 10.1016/j.febslet.2014.07.018. Epub 2014 Jul 24.